Company Profiles

driven by the PitchBook Platform

arGentis Pharmaceuticals

Description

Developer of orphan drugs for diffuse systemic scleroderma. The company offers treatment for systemic scleroderma (SSc), an autoimmune disease and focuses on treating underlying mechanisms of inflammatory conditions through utilization of oral and trans-dermal compounds.

2007

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

1

Investors

Description

Developer of orphan drugs for diffuse systemic scleroderma. The company offers treatment for systemic scleroderma (SSc), an autoimmune disease and focuses on treating underlying mechanisms of inflammatory conditions through utilization of oral and trans-dermal compounds.

Website:

www.argentisrx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology
Drug Discovery

Primary Office

1016 West Poplar Avenue Suite 106-238 Collierville, TN 38017United States +1 (901) 881-8665
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore arGentis Pharmaceuticals's full profile, request a free trial.

arGentis Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

arGentis Pharmaceuticals Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Innova MemphisVenture CapitalMinority000 0000000 0000
Innova Memphis Venture Capital

arGentis Pharmaceuticals Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Tom DavisChief Executive Officer, Co-Founder & President
Ralph HendersonChief Marketing Officer
Arnold Postlethwaite MDChief Scientific Officer & Lead Researcher
William CochranExecutive Director
Andrew Kang MDChief Medical Officer
Tom Davis Chief Executive Officer, Co-Founder & President
Ralph Henderson Chief Marketing Officer
Arnold Postlethwaite MD Chief Scientific Officer & Lead Researcher
William Cochran Executive Director
Andrew Kang MD Chief Medical Officer
Request full access to PitchBook